European Association of Dermato-Oncology 11th World Congress of Melanoma and 21st EADO Congress 2025

European Association of Dermato-Oncology 11th World Congress of Melanoma and 21st EADO Congress 2025

The 11th World Congress of Melanoma combined with the 21st EADO Congress 2025 is a premier international event uniting specialists from around the globe to advance knowledge and practice in dermato-oncology. This congress offers a rich scientific program with plenary sessions, interactive symposia, workshops, and case-based learning covering every aspect of melanoma and skin cancer management.

What You Will Learn

• Latest advances in prevention, diagnosis, staging, and treatment of melanoma and other skin cancers

• Innovative surgical and non-surgical therapies, including immunotherapy and targeted treatments

• Case-based discussions focusing on complex and rare cutaneous tumors

• Gross and microscopic pathology reviews presented by leading experts

• Advocacy and public health sessions addressing awareness, screening, and patient engagement

Event Details

• Dates: April 3–5, 2025

• Location: Megaron Athens International Conference Centre, Athens, Greece

Who Should Attend
This congress is ideal for:

• Dermatologists, oncologists, surgeons, and pathologists specializing in skin cancer

• Researchers and clinicians seeking the latest scientific updates in dermato-oncology

• Residents and fellows aiming to expand their expertise and network with world leaders in the field

• Healthcare advocates interested in advancing melanoma awareness and policy

Why Attend

• Gain cutting-edge knowledge from international experts across multiple specialties

• Participate in highly interactive and practical learning sessions

• Network with peers and key opinion leaders in a dynamic, global environment

• Experience an inspiring educational program in one of Europe’s most historic and vibrant cities

• CLOSING.mp4
  DERMOSCOPY CONTEST I.mp4
  DERMOSCOPY CONTEST II.mp4
  Final_Programm_WCM2025_V5.pdf
  FREE COMMUNICATION I Melanoma – systemic therapy other than ICI therapy.mp4
  FREE COMMUNICATION II Squamous cell carcinoma + rare tumors.mp4
  FREE COMMUNICATION III Melanoma – Epidemiology and diagnostics.mp4
  FREE COMMUNICATION IV Melanoma – Experimental and translational studies.mp4
  FREE COMMUNICATION V Melanoma – Surgery.mp4
  FREE COMMUNICATION VI Basal cell carcinoma.mp4
  FREE COMMUNICATION VII Melanoma – Immune checkpint inhibitor (ICI) therapy.mp4
  KEYNOTE LECTURE KEY01 Skin cancer epidemic- is there light at the end of the tunnel.mp4
  KEYNOTE LECTURE KEY02 The journey from melanocytes to melanoma.mp4
  KEYNOTE LECTURE KEY03 Diagnostic tools for skin cancer detection beyond dermoscopy.mp4
  KEYNOTE LECTURE KEY04 New diagnostics, prognostic biomarkers and systemic therapy strategies sharply reduce the need for surgery in melanoma.mp4
  KEYNOTE LECTURE KEY05 Neoadjuvant therapy- a new standard of care for melanoma.mp4
  KEYNOTE LECTURE KEY06 Improving outcomes in melanoma beyond the standard use of immune checkpoint blockers.mp4
  KEYNOTE LECTURE KEY07 The future of non-melanoma skin cancer treatment.mp4
  Opening Ceremony.mp4
  SATELLITE SYMPOSIUM SAT01 Platinum Sponsor.mp4
  SATELLITE SYMPOSIUM SAT02 Gold Sponsor.mp4
  SATELLITE SYMPOSIUM SAT03 Silver Sponsor.mp4
  SATELLITE SYMPOSIUM SAT04 Silver Sponsor.mp4
  SATELLITE SYMPOSIUM SAT05 Further Sponsor.mp4
  SATELLITE SYMPOSIUM SAT06 Further Sponsor.mp4
  SATELLITE SYMPOSIUM SAT07 Silver Sponsor.mp4
  SATELLITE SYMPOSIUM SAT08 Gold Sponsor.mp4
  SATELLITE SYMPOSIUM SAT09 Further Sponsor.mp4
  SATELLITE SYMPOSIUM SAT10 Platinum Sponsor.mp4
  SATELLITE SYMPOSIUM SAT11 Further Sponsor.mp4
  SOCRATES’ DIALOGUES I- AN INTERACTIVE MORNING SESSION The role of microbiome for immunotherapies.mp4
  SOCRATES’ DIALOGUES II- AN INTERACTIVE MORNING SESSION Treatment refractory stage IV melanomas- what do I do.mp4
  SOCRATES’ DIALOGUES III- AN INTERACTIVE MORNING SESSION Women in dermato-oncology.mp4
  SOCRATES’ DIALOGUES IV- AN INTERACTIVE MORNING SESSION Prognostic and predictive biomarkers for melanoma.mp4
  SOCRATES’ DIALOGUES V- AN INTERACTIVE MORNING SESSION Challenges in neoadjuvant therapy.mp4
  SOCRATES’ DIALOGUES VI- AN INTERACTIVE MORNING SESSION How to build up a career in dermato-oncology.mp4
  SYMPOSIUM SY01 Controversies – Skin cancer screening should be abandoned.mp4
  SYMPOSIUM SY02 Dermoscopy 1- Total body photography, digital dermoscopy and scanners- indications and procedures.mp4
  SYMPOSIUM SY03 Prognostic and predictive biomarkers in melanoma.mp4
  SYMPOSIUM SY04 Squamous cell carcinoma- epidemiology and management.mp4
  SYMPOSIUM SY05 Merkel cell carcinoma- epidemiology, surgery and radiology.mp4
  SYMPOSIUM SY06 Controversies – Does melanoma follow-up contribute to overall survival improvement.mp4
  SYMPOSIUM SY07 Basal cell carcinoma- epidemiology and management.mp4
  SYMPOSIUM SY08 Intralesional therapies of skin cancer.mp4
  SYMPOSIUM SY09 Liquid biopsy as a decision maker in melanoma.mp4
  SYMPOSIUM SY10 Melanoma classifications- past, present and future.mp4
  SYMPOSIUM SY11 Treatment of cutaneous lymphomas- what’s coming from the pipeline.mp4
  SYMPOSIUM SY12 Adoptive T-Cell transfer (TILs) for advanced melanomas.mp4
  SYMPOSIUM SY13 Interdisciplinary tumor board- challenging skin cancer cases I.mp4
  SYMPOSIUM SY14 Overdiagnosis of melanoma- a real problem.mp4
  SYMPOSIUM SY15 Neoadjuvant treatment of melanoma.mp4
  SYMPOSIUM SY16 Melanoma guidelines around the world.mp4
  SYMPOSIUM SY17 Immunotherapy of Merkel cell carcinoma.mp4
  SYMPOSIUM SY18 Primary ocular melanoma- genetics, clinical appearance and treatment.mp4
  SYMPOSIUM SY19 Artificial Intelligence in dermato-oncology.mp4
  SYMPOSIUM SY20 Registries for real world treatment data and outcome research.mp4
  SYMPOSIUM SY21 Memorial Symposium for Jeff Weber Drug resistance to immune checkpoint inhibition.mp4
  SYMPOSIUM SY22 Skin Care in Organ Transplant Patients Europe (SCOPE).mp4
  SYMPOSIUM SY23 Melanoma research.mp4
  SYMPOSIUM SY24 Congenital nevi- risk and management.mp4
  SYMPOSIUM SY25 Management of mucosal melanoma.mp4
  SYMPOSIUM SY26 Microbiome in cancer- more than gut feelings.mp4
  SYMPOSIUM SY27 Controversies – Is there a future for sentinel node biopsy.mp4
  SYMPOSIUM SY28 Drug resistance to targeted therapies.mp4
  SYMPOSIUM SY29 Molecular tumor board for skin cancers.mp4
  SYMPOSIUM SY30 Treatment of field cancerization including actinic cheilitis.mp4
  SYMPOSIUM SY31 Adjuvant treatment of melanoma.mp4
  SYMPOSIUM SY32 Management of brain metastasis.mp4
  SYMPOSIUM SY33 Radiotherapy for melanoma and other skin cancers- where are we now.mp4
  SYMPOSIUM SY34 Surgical pearls in the treatment of skin cancer.mp4
  SYMPOSIUM SY35 Rare skin tumors (adnexal, sebaceous, DFSP).mp4
  SYMPOSIUM SY36 Global epidemiologic trends and survival in skin cancer.mp4
  SYMPOSIUM SY37 High-risk melanocytic nevi- are they existing, and how to define what to do.mp4
  SYMPOSIUM SY38 Drug access across the world- approval is not reimbursement.mp4
  SYMPOSIUM SY39 Occupational skin cancer- The sleeping giant (4th Multi-stakeholder summit).mp4
  SYMPOSIUM SY40 Skin cancer on colored skin- clinical appearance and treatment.mp4
  SYMPOSIUM SY41 Mohs micrographic surgery and skin cancer management.mp4
  SYMPOSIUM SY42 Immune checkpoint inhibition for non-melanoma skin cancer.mp4
  SYMPOSIUM SY43 Immunotherapies of metastatic ocular melanoma in first- and second line.mp4
  SYMPOSIUM SY44 Cutaneous sarcomas- diagnosis and treatment.mp4
  SYMPOSIUM SY45 Primary prevention of skin cancer.mp4
  SYMPOSIUM SY46 Is there a future for sentinel node biopsy.mp4
  SYMPOSIUM SY47 Patient Advocacy Groups.mp4
  SYMPOSIUM SY48 Interdisciplinary tumor board- challenging skin cancer cases II.mp4
  SYMPOSIUM SY49 New devices for ..mp4
  SYMPOSIUM SY50 Management of adverse events in immuno-oncology.mp4
  SYMPOSIUM SY51 Promising agents for PD1-refractory patients.mp4
  SYMPOSIUM SY52 Melanoma pathology – genomics and morphology.mp4
  SYMPOSIUM SY53 Treatment at the end of the life.mp4
  SYMPOSIUM SY54 Management of adverse events in targeted therapies.mp4
  SYMPOSIUM SY55 Management of lentigo maligna and acral lentiginous melanomas.mp4
  SYMPOSIUM SY56 Immune checkpoint inhibition in immunocompromised patients.mp4
  SYMPOSIUM SY57 Melanocytic lesions of unknown potential- biology, prognosis, treatment and follow-up.mp4
  SYMPOSIUM SY58 Dermoscopy 2- Dermoscopy in melanoma management.mp4
  SYMPOSIUM SY59 Actinic keratosis- current treatment and future perspectives.mp4
  SYMPOSIUM SY60 Diagnosis and management of cutaneous T-and B-cell lymphomas.mp4
  SYMPOSIUM SY61 Interdisciplinary tumor board- challenging skin cancer cases III.mp4
  SYMPOSIUM SY62 Dermoscopy 3- Difficult clinical scenarios.mp4
  SYMPOSIUM SY63 Surgery of stage IV melanoma- still needed.mp4
  SYMPOSIUM SY64 Current primary staging and follow-up recommendations for melanoma patients.mp4
  SYMPOSIUM SY65 Genetic susceptibility of melanoma and cancer syndromes.mp4